ConductScience.org, home

Paper1752779

Human tumor-infiltrating lymphocytes transfected with tumor necrosis factor gene could augment cytotoxicity to autologous tumor cells.

Itoh Y and 9 others. Jpn J Cancer Res, 1991. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Human tumor-infiltrating lymphocytes transfected with tumor necrosis factor gene could augment cytotoxicity to autologous tumor cells. Papers, record 1752779. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1752779

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Human tumor-infiltrating lymphocytes transfected with tumor necrosis factor gene could augment cytotoxicity to autologous tumor cells.
PubMed
Journal
Jpn J Cancer Res
PubMed
Year
1991
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.24
iCite
Revised in PubMed
2019-05-10
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Itoh YY
2Kohgo YY
3Watanabe NN
4Kanisawa YY
5Sakamaki SS
6Takahashi MM
7Hirayama YY
8Ono HH
9Himeno TT
10Niitsu YY

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytotoxicity, ImmunologicMajor topic
Lung NeoplasmsMajor topic
Lymphocytes, Tumor-InfiltratingMajor topic
Stomach NeoplasmsMajor topic
TransfectionMajor topic
Tumor Necrosis Factor-alphaMajor topic
Ascites
Cell Line
Humans
Interleukin-2
Pleural Effusion
Recombinant Proteins

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12379159Expression of endogenous tumor necrosis factor as a protective protein against the cytotoxicity of exogenous tumor necrosis factor.Cancer Res1990https://conductscience.org/library/papers/2379159PubMed
23784109Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor.Jpn J Med Sci Biol1986https://conductscience.org/library/papers/3784109PubMed
32381442Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction.N Engl J Med1990https://conductscience.org/library/papers/2381442PubMed
42793231Functional interactions of IL2 and TNF in the differentiation of LGL into LAK effectors.Int J Cancer1989https://conductscience.org/library/papers/2793231PubMed
53936830Antitumor effect of tumor necrosis factor against various primarily cultured human cancer cells.Jpn J Cancer Res1985https://conductscience.org/library/papers/3936830PubMed
62493053Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytes.J Immunol1989https://conductscience.org/library/papers/2493053PubMed
73257408
Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity.
Cancer Res1988https://conductscience.org/library/papers/3257408PubMed
83489188Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor.Nature1986https://conductscience.org/library/papers/3489188PubMed
92644399Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma.J Clin Oncol1989https://conductscience.org/library/papers/2644399PubMed
103486936Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.J Exp Med1986https://conductscience.org/library/papers/3486936PubMed
116170674Natural cytotoxicity and interferon production in human cancer: deficient natural killer activity and normal interferon production in patients with advanced disease.J Immunol1981https://conductscience.org/library/papers/6170674PubMed
123315281Phase I study of recombinant human tumor necrosis factor.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3315281PubMed
131103152An endotoxin-induced serum factor that causes necrosis of tumors.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/1103152PubMed
146286831Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.J Mol Appl Genet1982https://conductscience.org/library/papers/6286831PubMed
152433337Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells.J Immunol1987https://conductscience.org/library/papers/2433337PubMed
162823261Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.Proc Natl Acad Sci U S A1987https://conductscience.org/library/papers/2823261PubMed
173108384Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells.J Immunol1987https://conductscience.org/library/papers/3108384PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
11319616
Administration of subtumor regression dosage of TNF-alpha to mice with pre-existing parental tumors augments the vaccination effect of TNF gene-modified tumor through the induction of MHC class I molecule.
Gene Ther2001https://conductscience.org/library/papers/11319616PubMed
8188531Augmented systemic immunity in mice implanted with tumor necrosis factor-alpha gene-transduced Meth-A-cells.Jpn J Cancer Res1994https://conductscience.org/library/papers/8188531PubMed
8162610Activation of tumor-infiltrating macrophages by a synthetic lipid A analog (ONO-4007) and its implication in antitumor effects.Cancer Immunol Immunother1994https://conductscience.org/library/papers/8162610PubMed
7882388
Characterization of tumor-necrosis-factor-gene-transduced tumor-infiltrating lymphocytes from ascitic fluid of cancer patients: analysis of cytolytic activity, growth rate, adhesion molecule expression and cytokine production.
Cancer Immunol Immunother1995https://conductscience.org/library/papers/7882388PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1752779

GET https://conductscience.org/api/papers/v1/1752779/authors